These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 24236804)
1. Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association? Castain C; Sempoux C; Brunt EM; Causse O; Heitzmann A; Hernandez-Prera JC; Le Bail B; Schirmacher P; Thung SN; Balabaud C; Bioulac-Sage P Histopathology; 2014 May; 64(6):890-5. PubMed ID: 24236804 [TBL] [Abstract][Full Text] [Related]
2. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623 [TBL] [Abstract][Full Text] [Related]
3. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up. Shafizadeh N; Genrich G; Ferrell L; Kakar S Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201 [TBL] [Abstract][Full Text] [Related]
4. Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours. Balabaud C; Laurent C; Le Bail B; Castain C; Possenti L; Frulio N; Chiche L; Blanc JF; Bioulac-Sage P Liver Int; 2018 Jul; 38(7):1273-1279. PubMed ID: 29265678 [TBL] [Abstract][Full Text] [Related]
5. Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings. Laumonier H; Cailliez H; Balabaud C; Possenti L; Zucman-Rossi J; Bioulac-Sage P; Trillaud H AJR Am J Roentgenol; 2012 Aug; 199(2):341-8. PubMed ID: 22826395 [TBL] [Abstract][Full Text] [Related]
6. Steatotic hepatocellular adenomas with different phenotypic subtypes: a case report. Alberti N; Castain C; Crombe A; Frulio N Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):e17-22. PubMed ID: 25260568 [TBL] [Abstract][Full Text] [Related]
7. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Laumonier H; Bioulac-Sage P; Laurent C; Zucman-Rossi J; Balabaud C; Trillaud H Hepatology; 2008 Sep; 48(3):808-18. PubMed ID: 18688875 [TBL] [Abstract][Full Text] [Related]
8. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417 [TBL] [Abstract][Full Text] [Related]
9. Retrospective study of hepatocellular adenomas based on the phenotypic classification system: A report from China. Pan J; Chen L; Fan J; Zhou J; Qin L; Tan Y; Ji Y; Huang X Histol Histopathol; 2014 Feb; 29(2):243-9. PubMed ID: 23939475 [TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Adenomas: Morphology and Genomics. Bioulac-Sage P; Sempoux C; Balabaud C Gastroenterol Clin North Am; 2017 Jun; 46(2):253-272. PubMed ID: 28506364 [TBL] [Abstract][Full Text] [Related]
11. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Bioulac-Sage P; Cubel G; Balabaud C; Zucman-Rossi J Semin Liver Dis; 2011 Feb; 31(1):91-103. PubMed ID: 21344354 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. Calderaro J; Labrune P; Morcrette G; Rebouissou S; Franco D; Prévot S; Quaglia A; Bedossa P; Libbrecht L; Terracciano L; Smit GP; Bioulac-Sage P; Zucman-Rossi J J Hepatol; 2013 Feb; 58(2):350-7. PubMed ID: 23046672 [TBL] [Abstract][Full Text] [Related]
13. Repeat surgery in HNF1alpha-inactivated adenomatosis. Balabaud C; Laurent C; Frulio N; Marie Christine SP; Le Bail B; Possenti L; Blanc JF; Chiche L; Bioulac-Sage P Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):460-467. PubMed ID: 30902584 [TBL] [Abstract][Full Text] [Related]
14. Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis. Pelletier L; Rebouissou S; Paris A; Rathahao-Paris E; Perdu E; Bioulac-Sage P; Imbeaud S; Zucman-Rossi J Hepatology; 2010 Feb; 51(2):557-66. PubMed ID: 20041408 [TBL] [Abstract][Full Text] [Related]
15. Hepatocellular adenomas in the Turkish population: reclassification according to updated World Health Organization criteria. Deniz K; Umetsu SE; Ferrell L; Yılmaz F; Güllüoğlu M; Sağol Ö; Doğusoy GB; Kırımlıoğlu H; Turhan N; Doran F; Kepil N; Çelikel ÇA; Nart D; Özgüven BY; Ceyran B; Karadağ N; Kır G; Erden E; Yılmaz G; Akyol G Histopathology; 2021 Jul; 79(1):23-33. PubMed ID: 33406290 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes. Bioulac-Sage P; Cubel G; Taouji S; Scoazec JY; Leteurtre E; Paradis V; Sturm N; Nhieu JT; Wendum D; Bancel B; Ramos J; Paraf F; Saint Paul MC; Michalak S; Fabre M; Guettier C; Le Bail B; Zucman-Rossi J; Balabaud C Am J Surg Pathol; 2012 Nov; 36(11):1691-9. PubMed ID: 23060349 [TBL] [Abstract][Full Text] [Related]
17. Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders. Sempoux C; Paradis V; Komuta M; Wee A; Calderaro J; Balabaud C; Quaglia A; Bioulac-Sage P J Hepatol; 2015 Nov; 63(5):1173-80. PubMed ID: 26119687 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte nuclear factor-1 α inactivated hepatocellular adenomas in patient with congenital absence of the portal vein: a case report. Tateishi Y; Furuya M; Kondo F; Torii I; Nojiri K; Tanaka Y; Umeda S; Okudela K; Inayama Y; Endo I; Ohashi K Pathol Int; 2013 Jul; 63(7):358-63. PubMed ID: 23865574 [TBL] [Abstract][Full Text] [Related]